Health
South African virus mutation raises questions over vaccine effectiveness – The Times of Israel
Scientists express concern over E484K strain, which Cambridge microbiologist warns ‘could be the start of problems for spike vaccines’ developed by Pfizer, Moderna…
PARIS (AFP) — As the British coronavirus variant occupies countries’ pandemic plans due to its increased transmissibility, other mutations to the Sars-CoV-2 are provoking concern among scientists who are scrambling to work out if they will respond to vaccines.
In particular, one mutation, known as E484K, detected initially in South Africa and on subsequent variants in Brazil and Japan, has raised alarm among researchers.
Ravi Gupta, professor of microbiology at the University of Cambridge, said…
-
Noosa News18 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News17 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General21 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General14 hours agoQantas ‘contacted by potential cybercriminal’ after attack on data of up to 6 million customers